Hjem › B-celle lymfom › Pennsylvania › Philadelphia
Kliniske studier for B-celle lymfom i Philadelphia, PA
11 studier for B-celle lymfom søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RekruttererFase 1
- Children's Hospital of Philadelphia, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
- Children's Hospital of Philadelphia, Philadelphia
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- University of Pennsylvania Abramson Cancer Center, Philadelphia
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Philadelphia
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruttererFase 1/2
- Fox Chase Cancer Center, Philadelphia
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RekruttererFase 1/2
- Research Site, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekruttererFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CD45BE-HSPC + CART-45 Cells
RekruttererFase 1
- University of Pennsylvania, Philadelphia
SynKIR-310 for Relapsed/Refractory B-NHL
RekruttererFase 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Children's Hospital of Philadelphia, Philadelphia
B-celle lymfom-studier i andre byer
- New York City, NY18 studier
- Houston, TX16 studier
- Chicago, IL13 studier
- Nashville, TN11 studier
- Rochester, MN10 studier
- Milwaukee, WI9 studier
- Baldwin Park, CA9 studier
- Cleveland, OH9 studier
- Boston, MA8 studier
- Salt Lake City, UT8 studier
- Washington, DC7 studier
- Pittsburgh, PA7 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.